Royal Bank Of Canada Psychemedics Corp Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.25 - $2.88 $27 - $34	-12 Reduced 19.35%	50 $0
Q1 2024 Nov 05, 2024	BUY	$2.92 - $3.79 $35 - $45	12 Added 24.0%	62 $0
Q1 2024 May 15, 2024	BUY	$2.92 - $3.79 $99 - $128	34 Added 121.43%	62 $0
Q4 2023 Feb 14, 2024	SELL	$2.06 - $3.69 $4,338 - $7,771	-2,106 Reduced 98.69%	28 $0
Q3 2023 Nov 14, 2023	SELL	$3.66 - $5.05 $40 - $55	-11 Reduced 0.51%	2,134 $8,000
Q2 2023 Aug 14, 2023	BUY	$4.55 - $5.6 $9,759 - $12,012	2,145 New	2,145 $9,000
Q3 2022 Nov 14, 2022	BUY	$6.08 - $6.84 $212 - $239	35 New	35 $0
Q4 2021 Feb 14, 2022	SELL	$6.86 - $8.79 $34 - $43	-5 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.25 - $8.25 $31 - $41	5 New	5 $0

1.24M

Ticker PMD
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 5,626,200
Market Cap $13.2M
Description
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.